Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-6158|4|2|119-137

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.4, Iss.2, 2004-06, pp. : 119-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exploiting the Diversity of the Heat-Shock Protein Family for Primary and Secondary Tauopathy Therapeutics

By  

Current Neuropharmacology, Vol. 9, Iss. 4, 2011-12 ,pp. : 623-631

Bentham Science Publishers

Access to resources Recommend Favorite

The Prevalence, Morbidities, and Treatments of Insomnia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 1, 2007-02 ,pp. : 3-16

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutics for primary peritoneal cancer

By Slomovitz Brian M   Worley Michael J   Markman Maurie   Coleman Robert L  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 1, 2011-03 ,pp. : 71-84

Informa Healthcare

Access to resources Recommend Favorite

Nanomedicines as Cancer Therapeutics: Current Status

By  

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-01 ,pp. : 362-378

Bentham Science Publishers

Access to resources Recommend Favorite

Schizophrenia: Genesis, Receptorology and Current Therapeutics

By  

Current Medicinal Chemistry, Vol. 9, Iss. 5, 2002-03 ,pp. : 521-548

Bentham Science Publishers

Access to resources Recommend Favorite